Publications by authors named "Norihiro Furusyo"

Claim this Profile
F
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.
Eiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi, Kazufumi Dohmen, Aritsune Ooho, Norihiro Furusyo

J Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals.
Eiichi Ogawa, Akira Kawano, Motoyuki Kohjima, Toshimasa Koyanagi, Kazufumi Dohmen, Norihiro Furusyo

J Gastroenterol Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study.
Hiroaki Ikezaki, Ryoko Nakashima, Yuji Matsumoto, Azusa Ohta, Sho Yamasaki, Norihiro Furusyo

Atheroscler Plus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of the association between antibody titre and pathogenicity before and after eradication: results of the Kyushu and Okinawa population study, a retrospective observational cohort study.
Sho Yamasaki, Masayuki Murata, Azusa Ohta, Yuji Matsumoto, Hiroaki Ikezaki, Norihiro Furusyo

BMJ Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.
Fanpu Ji, Sally Tran, Eiichi Ogawa, Chung-Feng Huang, Takanori Suzuki, Norihiro Furusyo

J Clin Transl Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study.
Eiichi Ogawa, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Eileen L Yoon, Norihiro Furusyo

Aliment Pharmacol Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between the cholesterol and triglyceride content of lipoprotein subclasses and carotid intima-media thickness: A cross-sectional population-based study.
Hiroaki Ikezaki, Norihiro Furusyo, Masumi Ai, Mitsuyo Okazaki, Takuji Kohzuma

Clin Chim Acta· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication.
Azusa Ohta, Eiichi Ogawa, Masayuki Murata, Yuji Matsumoto, Sho Yamasaki, Norihiro Furusyo

J Med Virol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
Eiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta, Norihiro Furusyo, Eiji Kajiwara

J Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study.
Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi, Aritsune Ooho, Norihiro Furusyo

Aliment Pharmacol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study.
Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi, Aritsune Ooho, Norihiro Furusyo

Hepatol Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection.
Eiichi Ogawa, Akira Kawano, Aritsune Ooho, Norihiro Furusyo, Takeaki Satoh

J Gastroenterol Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals.
Eiichi Ogawa, Makoto Nakamuta, Norihiro Furusyo, Eiji Kajiwara, Kazufumi Dohmen

J Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Helicobacter pylori infection on fluid duodenal microbial community structure and microbial metabolic pathways.
Tadashi Maeda, Hiroaki Zai, Yuto Fukui, Yoshifumi Kato, Eri Kumade, Norihiro Furusyo

BMC Microbiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study Profile of the Japan Multi-institutional Collaborative Cohort (J-MICC) Study.
Kenji Takeuchi, Mariko Naito, Sayo Kawai, Mineko Tsukamoto, Yuka Kadomatsu, Norihiro Furusyo

J Epidemiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in Japan.
Hiroaki Ikezaki, Norihiro Furusyo, Ryoko Nakashima, Makiko Umemoto, Ken Yamamoto

BMJ Open· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of lifestyle factors with osteoporosis and fracture in postmenopausal women: a Japanese cohort study.
Jun Otonari, Hiroaki Ikezaki, Norihiro Furusyo, Nobuyuki Sudo

Menopause· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do neuroticism and extraversion personality traits influence disease-specific risk factors for mortality from cancer and cardiovascular disease in a Japanese population?
Jun Otonari, Hiroaki Ikezaki, Norihiro Furusyo, Nobuyuki Sudo

J Psychosom Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication.
Eiichi Ogawa, Hidenori Toyoda, Etsuko Iio, Dae Won Jun, Chung-Feng Huang, Norihiro Furusyo

Clin Infect Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased and More Heterogeneous Gadoxetic Acid Uptake of the Liver Parenchyma after Hepatitis C Virus Eradication by Direct Antiviral Agent.
Nobuhiro Fujita, Akihiro Nishie, Yoshiki Asayama, Kousei Ishigami, Tomohiro Nakayama, Norihiro Furusyo

Magn Reson Med Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between alcohol intake pattern and metabolic syndrome components and simulated change by alcohol intake reduction: A cross-sectional study from the Japan Multi-Institutional Collaborative Cohort Study.
Ippei Shimoshikiryo, Rie Ibusuki, Keiichi Shimatani, Daisaku Nishimoto, Toshiro Takezaki, Norihiro Furusyo

Alcohol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort.
Yasuhito Tanaka, Eiichi Ogawa, Chung-Feng Huang, Hidenori Toyoda, Dae Won Jun, Norihiro Furusyo

Hepatol Int· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression.
Hiroaki Ikezaki, Norihiro Furusyo, Yuya Yokota, Masumi Ai, Bela F Asztalos

J Atheroscler Thromb· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C.
Eiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta, Norihiro Furusyo, Eiji Kajiwara

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
Eiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta, Norihiro Furusyo, Toshimasa Koyanagi

Liver Int· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis